Barclays analyst Matt Miksic raised the price target on Johnson & Johnson (NYSE: JNJ) to $255.00 (from $234.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE